Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2009

01-09-2009 | Original Article

Gastrojejunal Stricture After Gastric Bypass and Efficacy of Endoscopic Intervention

Authors: Abraham Mathew, Michael A. Veliuona, Fedele J. DePalma, Robert N. Cooney

Published in: Digestive Diseases and Sciences | Issue 9/2009

Login to get access

Abstract

The Roux-en-Y gastric bypass procedure (RYGBP) is an effective treatment for morbid obesity. Anastomotic strictures are a common complication after RYGBP. This study examines the frequency of post-RYGBP gastrojejunal strictures (GJS), methods of evaluation, and the outcome of endoscopic intervention. Medical records of patients who had RYGBP for morbid obesity at our institution during four consecutive years were reviewed for patient demographics, medical comorbidities, surgical technique, and outcomes. Radiographic and endoscopic findings of those patients suspected to have GJS were noted. The impact of patient-related variables and surgical technique on risk of GJS, time to diagnosis of GJS, and treatment outcomes for GJS was determined. Of 888 patients, 503 had open RYGBP (57%) and 385 laparoscopic RYGBP (43%). Ninety-four patients (10.6%) underwent esophagogastroduodenoscopy (EGD) for possible GJS and 58 (6.5%) were found to have anastomotic stricture. Laparoscopic RYGBP was associated with increased incidence of GJS (43/385, 11.1%) compared with open RYGBP (15/503 or 2.9%, P = 0.0003). A total of 125 dilations were performed with an average of 2.2 dilations per patient. None of the strictures needed surgical revision. There were four perforations (3.2%) related to EGD. Mean time to diagnosis of GJS was 66.2 days. Eighty-seven of 94 patients underwent radiologic upper gastrointestinal (UGI) evaluation prior to EGD. UGI evaluation demonstrated a positive predictive value (PPV) of only 66% [95% confidence interval (CI) 52–77], and negative predictive value (NPV) of 83% (95% CI 65–93). Laparoscopic GBP is associated with increased risk of GJS. Endoscopic dilation of GJS is an effective treatment with minimal risk. Radiographic studies appear to have poor specificity for diagnosis of GJS and have a low positive predictive value. EGD should be performed in all suspected cases of GJS.
Literature
2.
go back to reference Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–1351.PubMed Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–1351.PubMed
5.
go back to reference DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235:640–5. Discussion 645–647. doi:10.1097/00000658-200205000-00005. DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235:640–5. Discussion 645–647. doi:10.​1097/​00000658-200205000-00005.
10.
go back to reference Nguyen NT, Ho HS, Palmer LS, Wolfe BM (2000) A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg. 191:149–55. Discussion 155–147. doi:10.1016/S1072-7515(00)00276-3. Nguyen NT, Ho HS, Palmer LS, Wolfe BM (2000) A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg. 191:149–55. Discussion 155–147. doi:10.​1016/​S1072-7515(00)00276-3.
23.
go back to reference Barba CA, Butensky MS, Lorenzo M, Newman R. Endoscopic dilation of gastroesophageal anastomosis stricture after gastric bypass. Surg Endosc. 2003;17:416–420.PubMedCrossRef Barba CA, Butensky MS, Lorenzo M, Newman R. Endoscopic dilation of gastroesophageal anastomosis stricture after gastric bypass. Surg Endosc. 2003;17:416–420.PubMedCrossRef
24.
go back to reference Nguyen NT. Open vs. laparoscopic procedures in bariatric surgery. J Gastrointest Surg. 2004;8:393–395.PubMedCrossRef Nguyen NT. Open vs. laparoscopic procedures in bariatric surgery. J Gastrointest Surg. 2004;8:393–395.PubMedCrossRef
25.
go back to reference Rossi TR, Dynda DI, Estes NC, Marshall JS. Stricture dilation after laparoscopic Roux-en-Y gastric bypass. Am J Surg. 2005;189:357–360.PubMedCrossRef Rossi TR, Dynda DI, Estes NC, Marshall JS. Stricture dilation after laparoscopic Roux-en-Y gastric bypass. Am J Surg. 2005;189:357–360.PubMedCrossRef
26.
go back to reference Swartz DE, Gonzalez V, Felix EL. Anastomotic stenosis after Roux-en-Y gastric bypass: a rational approach to treatment. Surg Obes Relat Dis. 2006;2:632–636. Discussion 637.PubMedCrossRef Swartz DE, Gonzalez V, Felix EL. Anastomotic stenosis after Roux-en-Y gastric bypass: a rational approach to treatment. Surg Obes Relat Dis. 2006;2:632–636. Discussion 637.PubMedCrossRef
27.
go back to reference Szomstein S, Kaidar-Person O, Naberezny K, Cruz-Correa M, Rosenthal R. Correlation of radiographic and endoscopic evaluation of gastrojejunal anastomosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:617–621.PubMedCrossRef Szomstein S, Kaidar-Person O, Naberezny K, Cruz-Correa M, Rosenthal R. Correlation of radiographic and endoscopic evaluation of gastrojejunal anastomosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2:617–621.PubMedCrossRef
Metadata
Title
Gastrojejunal Stricture After Gastric Bypass and Efficacy of Endoscopic Intervention
Authors
Abraham Mathew
Michael A. Veliuona
Fedele J. DePalma
Robert N. Cooney
Publication date
01-09-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0581-7

Other articles of this Issue 9/2009

Digestive Diseases and Sciences 9/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.